Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.

Skineez® Launches First-Ever Reversible Medical Grade Compression Sock-Made in the USA Clinically Proven, Skincare-Infused, ...

Healthcare distributor and services company Cardinal Health (NYSE:CAH) will be announcing earnings results this Tuesday ...

Key Insights Institutions' substantial holdings in Cardinal Health implies that they have significant influence ...

Healthcare earnings update: 93% of sector firms have reported, highlighting robust revenue growth & few misses.

Analysts expect the health care company to report quarterly earnings at $2.03 per share, up from $1.84 per share in the ...

Cardinal Health, Inc. (NYSE:CAH) will release earnings results for the fourth quarter before the opening bell on Tuesday, Aug ...

Blackstone, Cinven, Thoma Bravo, TPG and Silver Lake were among the PE firms completing deals that stood out. While many ...

As companies expand their tech stacks and accelerate digital operations, they may be ignoring risks rooted in shadow systems, ...

Owens & Minor missed EPS estimates in Q2, but sales and EBITDA grew as it advanced plans to sell one of its segments.

Bloomberg's large-cap BMVP portfolio delivered positive returns in 2Q but trailed its benchmarks, held back by its defensive tilt during one of the fastest market rebounds on record.

It looks like Danville will receive a share of funds from a nationwide opioid settlement agreement. The Danville City Council ...